Australian medicines regulator, the Therapeutic Goods Administration (TGA), has granted approval for mRESVIA (mRNA-1345), an ...

CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345), ...

The risk for new-onset or recurrent AF was not increased among older adult patients with preexisting conditions following RSV vaccination.

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

The Royal Australian College of GPs (RACGP) has thrown its support behind Victoria's infant RSV vaccine program.Respiratory syncytial virus, or RSV ...

Largest childhood preventative health initiative in nearly 20 yearsBeyfortus rollout to ensure all babies are RSV protected this winterThe largest ...

The resignation of one of the FDA's top officials, Peter Marks, is worrying Wall Street as they await a replacement.

The current recommended time for that vaccination, according to the Department of Health and Aged Care, is around April, with ...

The long-acting Respiratory Syncytial Virus (RSV) immunisation is now available free for eligible families until 30 September ...